MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells

Cisplatin chemoresistance is a clinical obstacle in the treatment of gastric cancer (GC). Enhanced DNA repair capacity may lead to cisplatin resistance. However, the detailed molecular mechanism of GC cisplatin resistance specifically involving nucleotide excision repair (NER) is not clear. However,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Cancer
Autores principales: Xie, Xiaoque, Huang, Nana, Zhang, Yiyin, Wei, Xiaoli, Gao, Mengru, Li, Min, Ning, Jie, Liu, Wei, Zhao, Qihong, Wang, Hua, Gu, Kangsheng
Formato: Artigo
Lenguaje:Inglês
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6400793/
https://ncbi.nlm.nih.gov/pubmed/30854110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.25814
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares